10 Oversold Healthcare Stocks To Invest In
Investing in healthcare stocks during lean economic times is generally regarded as defensive.
Organon & Co. (OGN)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 2,884,453 | $55,179,585 | +68% | 0.01% |
| 2. | AQR Capital Management Cliff Asness | 2,474,690 | $47,340,817 | -29% | 0.06% |
| 3. | Slate Path Capital David Greenspan | 2,463,963 | $47,135,612 | -55% | 0.72% |
| 4. | Kahn Brothers Irving Kahn | 1,835,193 | $35,107,592 | +11% | 6.04% |
| 5. | Weiss Asset Management Andrew Weiss | 1,723,243 | $32,965,639 | 0.75% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.36 | 2,720 | Officer | 15,181 | 2024-02-22 | Filing | |
| $33.79 | 3,000 | Director | 3,000 | 2021-08-19 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 33,523,293 | $483,405,887 | 0.01% | |
| 2. | 30,597,237 | $441,212,158 | 0% | |
| 3. | 10,211,008 | $147,242,735 | 0.04% | |
| 4. | 9,442,763 | $136,164,642 | 0% | |
| 5. | 5,859,028 | $84,487,222 | 0% |
News See All
Organon & Co. (NYSE:OGN) Q3 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Mandeep and I'll be your operator today. At this time, I'd like to welcome everyone to the Organon Q3 2024 earnings call webcast.
Organon & Co. (NYSE:OGN) Q2 2024 Earnings Call Transcript
Operator: Thank you for standing-by. My name is Mandeep, and I'll be your operator today. At this time, I'd like to welcome everyone to the Organon Q2 2024 Earnings Call and Webcast.
Organon & Co. (NYSE:OGN) Q1 2024 Earnings Call Transcript
Organon & Co. misses on earnings expectations. Reported EPS is $0.88 EPS, expectations were $0.97. Organon & Co.
12 Under-the-Radar Stocks With Massive Upside for 2024
In this piece, we will take a look at the 12 under the radar stocks with massive upside for 2024.
11 Best Low Price Pharma Stocks To Invest In
In this piece, we will take a look at the 13 best low price pharma stocks to invest in.
15 Best Affordable Dividend Stocks To Invest In Right Now
In this article, we will take a detailed look at the 15 Best Affordable Dividend Stocks To Invest In Right Now. For a quick overview of such stocks, read our article 5 Best Affordable Dividend Stocks...
13 Best Pharma Dividend Stocks To Buy in 2024
In this article, we discuss 13 best pharma dividend stocks to buy in 2024.
Organon & Co. (NYSE:OGN) Q4 2023 Earnings Call Transcript
Organon & Co. beats earnings expectations. Reported EPS is $0.88, expectations were $0.8. Organon & Co.
Do You Believe That Organon & Co. (OGN) is a Compelling Prospect for Long-Term, Patient Investors?
Sound Shore Management, an investment management firm, has released its investor letter for the fourth quarter of 2023. A copy of the same can be downloaded here.
Billionaire Hedge Funds
